Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BrightSphere Investment Group plcBSIG · Entity 156504 | Director | June 20, 2019 | June 24, 2019 |
| Strata Critical Medical, Inc.SRTA · Entity 5512 | Director | August 10, 2026 | August 13, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BrightSphere Investment Group plc
Report date June 20, 2019 · Filed June 24, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary sharesSEC Table I · non-derivative | Direct | 6,785 |
Ending reported balance
After 2019-06-21 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2019-06-20 · Exercise / conversion · Acquired 7,149 · Balance 7,149 Row 2 · 2019-06-21 · Sale · Disposed 364 · Balance 6,785 F1: Represents shares sold by the reporting person to cover tax withholding obligations upon the vesting of restricted shares. |
| Restricted Share UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2019-06-20 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2019-06-20 · Exercise / conversion · Disposed 7,149 · Balance 0 F2: Each restricted share unit represents a right to receive one ordinary share of BrightSphere Investment Group plc. F3: On June 20, 2018, the reporting person was granted 7,149 restricted share units, vesting fully on June 20, 2019. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares sold by the reporting person to cover tax withholding obligations upon the vesting of restricted shares.
F2: Each restricted share unit represents a right to receive one ordinary share of BrightSphere Investment Group plc.
F3: On June 20, 2018, the reporting person was granted 7,149 restricted share units, vesting fully on June 20, 2019.
Strata Critical Medical, Inc.
Report date August 10, 2026 · Filed August 13, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A common stock, $0.0001 par value per shareSEC Table I · non-derivative | Direct | 146,481 |
Reported balance
After 2026-08-10 transaction · row 1
1 source rowRow 1 · 2026-08-10 · Sale · Disposed 5,091 · Balance 146,481 |
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Acadian Asset Management Inc.
Report date June 24, 2020 · Filed June 26, 2020
Section 16 reporting ended · disclosed 2020-06-26. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 16,273 |
Reported balance
After 2020-06-24 transaction · row 1
1 source rowRow 1 · 2020-06-24 · Exercise / conversion · Acquired 9,488 · Balance 16,273 |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2020-06-24 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2020-06-24 · Exercise / conversion · Disposed 9,488 · Balance 0 F1: Each restricted stock unit represents a right to receive one share of common stock of BrightSphere Investment Group Inc. F2: On September 19, 2019, the reporting person was granted 9,488 restricted stock units, vesting upon the earlier of September 19, 2020 and the date of the 2020 annual meeting of stockholders of BrightSphere Investment Group Inc., which was held on June 24, 2020. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a right to receive one share of common stock of BrightSphere Investment Group Inc.
F2: On September 19, 2019, the reporting person was granted 9,488 restricted stock units, vesting upon the earlier of September 19, 2020 and the date of the 2020 annual meeting of stockholders of BrightSphere Investment Group Inc., which was held on June 24, 2020.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 10, 2026 Filed Aug 13, 2026 21:33 UTC | Strata Critical Medical, Inc. SRTA · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 5,091 | $5.75 | $29,273.25 |
DisclosureSEC source: 0001628280-26-056841 · wk-form4_1786656778.xml · nonDerivative · entry 1 Love Reginald · CIK 0001749370 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 146,481 Read SEC document |
| July 30, 2026 Filed Aug 3, 2026 20:07 UTC | Strata Critical Medical, Inc. SRTA · Entity 5512 | GrantClass A common stock, $0.0001 par value per share | 37,675 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-051824 · wk-form4_1785787630.xml · nonDerivative · entry 1 Love Reginald · CIK 0001749370 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 151,572 F1 · shares: Represents a grant of Restricted Stock Units ("RSUs"), which will be settled in shares of the Issuer's common stock upon vesting. 100% of the RSUs will become vested on the date of the Issuer's 2027 Annual Meeting of Stockholders. Read SEC document |
| November 20, 2025 Filed Nov 24, 2025 21:23 UTC | Strata Critical Medical, Inc. SRTA · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 11,000 | $4.37 | $48,070.00 |
DisclosureSEC source: 0001628280-25-053810 · wk-form4_1764019428.xml · nonDerivative · entry 1 Love Reginald · CIK 0001749370 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 113,897 Read SEC document |
| November 19, 2025 Filed Nov 20, 2025 21:07 UTC | Strata Critical Medical, Inc. SRTA · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 11,000 | $4.31 | $47,434.20 |
DisclosureSEC source: 0001628280-25-053386 · wk-form4_1763672833.xml · nonDerivative · entry 1 Love Reginald · CIK 0001749370 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 124,897 F1 · price: These transactions were executed in multiple trades at prices ranging from $4.31 to $4.32, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC, the Issuer, or a security holder of the Issuer full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| August 01, 2025 Filed Aug 5, 2025 22:14 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | GrantClass A common stock, $0.0001 par value per share | 35,534 | $0.00 | $0.00 |
DisclosureSEC source: 0001779128-25-000072 · wk-form4_1754432045.xml · nonDerivative · entry 1 Love Reginald · CIK 0001749370 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 135,897 F1 · shares: Represents a grant of Restricted Stock Units ("RSUs"), which will be settled in shares of the Issuer's common stock upon vesting. 100% of the RSUs will become vested on the date of the Issuer's 2026 Annual Meeting of Stockholders. Read SEC document |
| December 13, 2024 Filed Dec 17, 2024 21:33 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 5,091 | $4.05 | $20,619.06 |
DisclosureSEC source: 0001779128-24-000158 · wk-form4_1734471180.xml · nonDerivative · entry 1 Love Reginald · CIK 0001749370 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,363 Read SEC document |
| August 09, 2024 Filed Aug 13, 2024 15:49 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | GrantClass A common stock, $0.0001 par value per share | 42,826 | $0.00 | $0.00 |
DisclosureSEC source: 0001779128-24-000108 · wk-form4_1723564164.xml · nonDerivative · entry 1 Love Reginald · CIK 0001749370 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 105,454 F1 · shares: Represents a grant of Restricted Stock Units ("RSUs"), which will be settled in shares of the Issuer's common stock upon vesting. 100% of the RSUs will become vested on the date of the Issuer's 2025 Annual Meeting of Stockholders. Read SEC document |
| June 10, 2024 Filed Jun 12, 2024 21:42 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | PurchaseClass A common stock, $0.0001 par value per share | 5,091 | $2.99 | $15,196.64 |
DisclosureSEC source: 0001779128-24-000077 · wk-form4_1718228559.xml · nonDerivative · entry 1 Love Reginald · CIK 0001749370 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,628 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.985 to $2.994, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| November 24, 2023 Filed Nov 27, 2023 16:11 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 20,000 | $3.21 | $64,104.00 |
DisclosureSEC source: 0001779128-23-000125 · wk-form4_1701101480.xml · nonDerivative · entry 1 Love Reginald · CIK 0001749370 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,537 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.20 to $3.25, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| August 08, 2023 Filed Aug 9, 2023 21:30 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | GrantClass A common stock, $0.0001 par value per share | 31,178 | $0.00 | $0.00 |
DisclosureSEC source: 0001779128-23-000090 · wf-form4_169161663255919.xml · nonDerivative · entry 1 Love Reginald · CIK 0001749370 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,537 F1 · shares: Represents a grant of Restricted Stock Units ("RSUs"), which will be settled in shares of the Issuer's common stock upon vesting. 100% of the RSUs will become vested on the date of the Issuer's 2024 Annual Meeting of Stockholders. Read SEC document |
| May 18, 2022 Filed May 19, 2022 17:43 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | GrantClass A common stock, $0.0001 par value per share | 11,404 | $0.00 | $0.00 |
DisclosureSEC source: 0001779128-22-000050 · wf-form4_165298217858077.xml · nonDerivative · entry 1 Love Reginald · CIK 0001749370 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,359 F1 · shares: Represents a grant of Restricted Stock Units ("RSUs"), which will be settled in shares of the Issuer's common stock upon vesting: 25% of the RSUs (rounded down to the nearest whole number) to become vested every three months measured from May 7, 2022, with the remainder to become vested on May 7, 2023, such that the RSUs become 100% vested on May 7, 2023. Read SEC document |
| December 16, 2021 Filed Dec 20, 2021 16:54 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | GrantClass A common stock, $0.0001 par value per share | 34,955 | $0.00 | $0.00 |
DisclosureSEC source: 0001779128-21-000022 · wf-form4_164001924871492.xml · nonDerivative · entry 1 Love Reginald · CIK 0001749370 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,955 F1 · shares: Represents a grants of Restricted Stock Units ("RSUs"), which will be settled in shares of the Issuer's common stock upon vesting. 27,992 shares will vest in full on September 23, 2023. 6,963 shares will vest equally on February 7, 2022 and May 7, 2022, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 24, 2020 Filed Jun 26, 2020 20:37 UTC | Acadian Asset Management Inc. BSIG · Entity 4180 | Exercise / conversionRestricted Stock Units · Derivative | 9,488 | $0.00 | $0.00 |
DisclosureSEC source: 0001748824-20-000035 · wf-form4_159320382389549.xml · derivative · entry 2 Love Reginald · CIK 0001749370 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,488 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each restricted stock unit represents a right to receive one share of common stock of BrightSphere Investment Group Inc. F1 · derivative.exercise_price: Each restricted stock unit represents a right to receive one share of common stock of BrightSphere Investment Group Inc. F2 · derivative.exercise_date: On September 19, 2019, the reporting person was granted 9,488 restricted stock units, vesting upon the earlier of September 19, 2020 and the date of the 2020 annual meeting of stockholders of BrightSphere Investment Group Inc., which was held on June 24, 2020. F2 · derivative.expiration_date: On September 19, 2019, the reporting person was granted 9,488 restricted stock units, vesting upon the earlier of September 19, 2020 and the date of the 2020 annual meeting of stockholders of BrightSphere Investment Group Inc., which was held on June 24, 2020. Read SEC document |
| June 24, 2020 Filed Jun 26, 2020 20:37 UTC | Acadian Asset Management Inc. BSIG · Entity 4180 | Exercise / conversionCommon Stock | 9,488 | $0.00 | $0.00 |
DisclosureSEC source: 0001748824-20-000035 · wf-form4_159320382389549.xml · nonDerivative · entry 1 Love Reginald · CIK 0001749370 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,273 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 19, 2019 Filed Sep 19, 2019 20:09 UTC | Acadian Asset Management Inc. BSIG · Entity 4180 | GrantRestricted Stock Units · Derivative | 9,488 | $0.00 | $0.00 |
DisclosureSEC source: 0001748824-19-000057 · wf-form4_156892378192802.xml · derivative · entry 1 Love Reginald · CIK 0001749370 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,488 Underlying: Common Stock · 9,488 shares Expires not disclosed F1 · security: Each restricted stock unit represents a right to receive one share of common stock of BrightSphere Investment Group Inc. F1 · derivative.exercise_price: Each restricted stock unit represents a right to receive one share of common stock of BrightSphere Investment Group Inc. F2 · shares: Consists of restricted stock units issued under the BrightSphere Investment Group Inc. Non-Employee Directors' Equity Incentive Plan. F3 · derivative.exercise_date: The restricted stock units vest upon the earlier of September 19, 2020 and the date of the 2020 annual meeting of stockholders of BrightSphere Investment Group Inc. F3 · derivative.expiration_date: The restricted stock units vest upon the earlier of September 19, 2020 and the date of the 2020 annual meeting of stockholders of BrightSphere Investment Group Inc. Read SEC document |
| June 21, 2019 Filed Jun 24, 2019 20:20 UTC | BrightSphere Investment Group plc BSIG · Entity 156504 | SaleOrdinary shares | 364 | $11.01 | $4,007.64 |
DisclosureSEC source: 0001611702-19-000057 · wf-form4_156140763567525.xml · nonDerivative · entry 2 Love Reginald · CIK 0001749370 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,785 F1 · shares: Represents shares sold by the reporting person to cover tax withholding obligations upon the vesting of restricted shares. Read SEC document |
| June 20, 2019 Filed Jun 24, 2019 20:20 UTC | BrightSphere Investment Group plc BSIG · Entity 156504 | Exercise / conversionRestricted Share Units · Derivative | 7,149 | $0.00 | $0.00 |
DisclosureSEC source: 0001611702-19-000057 · wf-form4_156140763567525.xml · derivative · entry 3 Love Reginald · CIK 0001749370 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary shares · 7,149 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted share unit represents a right to receive one ordinary share of BrightSphere Investment Group plc. F3 · derivative.exercise_date: On June 20, 2018, the reporting person was granted 7,149 restricted share units, vesting fully on June 20, 2019. F3 · derivative.expiration_date: On June 20, 2018, the reporting person was granted 7,149 restricted share units, vesting fully on June 20, 2019. Read SEC document |
| June 20, 2019 Filed Jun 24, 2019 20:20 UTC | BrightSphere Investment Group plc BSIG · Entity 156504 | Exercise / conversionOrdinary shares | 7,149 | $0.00 | $0.00 |
DisclosureSEC source: 0001611702-19-000057 · wf-form4_156140763567525.xml · nonDerivative · entry 1 Love Reginald · CIK 0001749370 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,149 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 07, 2018 Filed Aug 8, 2018 20:30 UTC | BrightSphere Investment Group plc BSIG · Entity 156504 | GrantRestricted Share Units · Derivative | 7,149 | $0.00 | $0.00 |
DisclosureSEC source: 0001611702-18-000070 · wf-form4_153376019523599.xml · derivative · entry 1 Love Reginald · CIK 0001749370 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,149 Underlying: Ordinary shares · 7,149 shares Expires not disclosed F1 · security: Each restricted share unit represents a right to receive one ordinary share of BrightSphere Investment Group plc. F1 · derivative.exercise_price: Each restricted share unit represents a right to receive one ordinary share of BrightSphere Investment Group plc. F2 · shares: Consists of restricted share units issued under the BrightSphere Investment Group plc Non-Employee Directors' Equity Incentive Plan. F3 · derivative.exercise_date: The restricted share units vest upon the earlier of June 20, 2019 and the date of the 2019 annual general meeting of BrightSphere Investment Group plc. F3 · derivative.expiration_date: The restricted share units vest upon the earlier of June 20, 2019 and the date of the 2019 annual general meeting of BrightSphere Investment Group plc. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.